What is the likely cause of severe pain and redness in the first metatarsophalangeal joint in a 60-year-old man with a history of systemic hypertension, gout, and dyslipidemia, recently diagnosed with congestive heart failure and new-onset diabetes mellitus, and started on Lasix (furosemide), aspirin, Plavix (clopidogrel), and metformin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lasix (Furosemide) is the Most Likely Culprit

Lasix (furosemide), a loop diuretic, is the medication most likely responsible for precipitating this acute gout flare in this patient with a known history of gout. Loop diuretics are well-established triggers for gout attacks by decreasing uric acid excretion and elevating serum uric acid levels. 1

Mechanism and Evidence

Loop and thiazide diuretics are recognized as common and significant risk factors for gout exacerbations, with an odds ratio of 1.72. 2 The mechanism involves:

  • Diuretics elevate serum uric acid by increasing net uric acid reabsorption in the proximal tubule of the kidney. 3
  • This effect becomes noticeable shortly after treatment initiation and persists throughout therapy, occurring even at low doses. 3
  • The elevation in serum uric acid is dose-dependent and can precipitate acute gout flares in patients with pre-existing gout. 3

Clinical Context

This patient's presentation is particularly high-risk:

  • He has a known history of gout, making him susceptible to flares when serum uric acid rises. 1
  • Lasix was newly initiated 5 days ago for heart failure management, and the gout flare occurred within days of starting this medication—a temporal relationship consistent with diuretic-induced hyperuricemia. 3
  • The classic presentation of severe pain and redness in the first metatarsophalangeal joint strongly suggests acute gout. 1, 4

Why Not the Other Medications?

  • Aspirin: While aspirin can affect uric acid levels, low-dose aspirin (typically used for cardiovascular protection) has minimal impact on gout risk at the doses used in this clinical context. 5
  • Plavix (clopidogrel): This antiplatelet agent has no established association with gout precipitation. 6
  • Metformin: This antidiabetic medication is not known to trigger gout attacks and does not significantly affect serum uric acid levels. 7

Guideline-Based Management Recommendation

EULAR guidelines explicitly recommend that when gout occurs in a patient receiving loop or thiazide diuretics, the diuretic should be substituted if possible. 1 Specifically:

  • For hypertension management, consider switching to losartan (which has uricosuric properties) or calcium channel blockers. 1, 2
  • Losartan augments uric acid excretion and thereby decreases serum uric acid levels. 3
  • If diuretic therapy cannot be discontinued due to heart failure severity, the patient will require urate-lowering therapy and prophylaxis against future flares. 1

Critical Clinical Pitfall

Do not assume that because the patient "needs" diuretic therapy for heart failure, the diuretic cannot be modified. 2 Many patients can be managed with alternative heart failure regimens that minimize gout risk, and the cardiovascular benefits of ACE inhibitors or angiotensin receptor blockers (particularly losartan) may provide dual benefits. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gout Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiovascular drugs and serum uric acid.

Cardiovascular drugs and therapy, 2003

Guideline

Gout Presentation and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020

Related Questions

How to manage a patient with recurrent gout, hypertension, and impaired renal function, currently experiencing hypotension?
What is the most appropriate intervention to prevent future episodes of gout in a patient with hyperuricemia and a history of gout attacks?
How to manage a patient with impaired renal function and hyperuricaemia on Lisinopril (lisinopril), atorvastatin (atorvastatin), and bendroflumethiazide (bendroflumethiazide) with a history of gout and hypertension?
What is the cause of lower leg swelling in a 69-year-old female with type 2 diabetes mellitus (DM), chronic obstructive pulmonary disease (COPD), and impaired renal function, who was recently started on furosemide (Lasix) and is currently taking insulin (long-acting), simvastatin (Simvistat), and inhalers, with a hemoglobin A1C (HbA1C) of 12.1% and a glomerular filtration rate (GFR) of 50?
Can a patient with heart failure, impaired left ventricular (LV) function, gout, and hyperparathyroidism, who recently experienced an exacerbation due to medication non-compliance, return to work, and if so, when?
What are the treatment options for a patient with acute sinusitis, considering underlying allergies or asthma?
What are the implications of a gallbladder ejection fraction of 14% and recommended treatment options?
What is the most effective and affordable Glucagon-like peptide-1 (GLP-1) receptor agonist, such as liraglutide (Saxenda) or semaglutide (Wegovy), for a patient seeking weight loss?
What are the causes and treatment options for generalized pruritis (itching) in an adult male that occurs both day and night?
What are the next steps in managing a patient with diverticulitis, ostomy formation with increased output, and uncontrolled type 1 diabetes, currently on Imodium (loperamide) with no blood in stoma?
Is a hemoglobin (Hgb) level of 10.5 and a platelet count of 503 significant and does it warrant referral to a hematologist?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.